Invest in Sonnet BioTherapeutics Holdings Inc. (SONN) to keep your portfolio healthy

The price of Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) closed at $0.99 in the last session, down -10.86% from day before closing price of $1.11. In other words, the price has decreased by -$0.1205 from its previous closing price. On the day, 551266 shares were traded. SONN stock price reached its highest trading level at $1.1200 during the session, while it also had its lowest trading level at $0.9805.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



We take a closer look at SONN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 9.14 while its Price-to-Book (P/B) ratio in mrq is 5.50.

Stock Price History:

Over the past 52 weeks, SONN has reached a high of $9.37, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 1.5270, while the 200-Day Moving Average is calculated to be 3.4639.

Shares Statistics:

According to the various share statistics, SONN traded on average about 4.31M shares per day over the past 3-months and 412.87k shares per day over the past 10 days. A total of 7.35M shares are outstanding, with a floating share count of 7.23M. Insiders hold about 1.72% of the company’s shares, while institutions hold 3.50% stake in the company. Shares short for SONN as of Oct 13, 2022 were 169.84k with a Short Ratio of 0.14M, compared to 42.72k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.92% and a Short% of Float of 4.05%.

Earnings Estimates

The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$1.51 for the current quarter, with a high estimate of -$1.51 and a low estimate of -$1.51, while EPS last year was -$2.45. The consensus estimate for the next quarter is -$1.15, with high estimates of -$1.15 and low estimates of -$1.15.

Analysts are recommending an EPS of between -$6.68 and -$6.68 for the fiscal current year, implying an average EPS of -$6.68. EPS for the following year is -$4.91, with 1 analysts recommending between -$4.91 and -$4.91.

Revenue Estimates

A total of 1 analysts have provided revenue estimates for SONN’s current fiscal year. The highest revenue estimate was $400k, while the lowest revenue estimate was $400k, resulting in an average revenue estimate of $400k. In the same quarter a year ago, actual revenue was $484k, down -17.40% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $100k in the next fiscal year. The high estimate is $100k and the low estimate is $100k. The average revenue growth estimate for next year is down -75.00% from the average revenue estimate for this year.